{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:50:07Z","timestamp":1783486207798,"version":"3.55.0"},"reference-count":14,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T00:00:00Z","timestamp":1400457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Peninsula Clahrc (Partly funded to support data collection)","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Two widely used antithyroid drug (<jats:styled-content style=\"fixed-case\">ATD<\/jats:styled-content>) regimes for Graves\u2019 disease (<jats:styled-content style=\"fixed-case\">GD<\/jats:styled-content>) include the \u2018block &amp; replace\u2019 (B&amp;R) regime (a fixed high\u2010dose of <jats:styled-content style=\"fixed-case\">ATD<\/jats:styled-content> combined with levothyroxine) and the \u2018titration\u2019 regime (a titrating dose of <jats:styled-content style=\"fixed-case\">ATD<\/jats:styled-content>). Anecdotally, it is believed that B&amp;R is less prone to fluctuating thyroid function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To study whether, in routine clinical practice, the B&amp;R regime, compared with the titration regime, is associated with more stable thyroid function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analysed case\u2010records for 450 patients treated with <jats:styled-content style=\"fixed-case\">ATD<\/jats:styled-content>s for <jats:styled-content style=\"fixed-case\">GD<\/jats:styled-content> at a secondary care hospital. Exclusion criteria included treatment with <jats:styled-content style=\"fixed-case\">ATD<\/jats:styled-content>s for &lt;6\u00a0months, thyrotoxicosis due to other causes, treatment with radioiodine or thyroidectomy and pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two hundred and twenty three patients were treated with the B&amp;R regime (\u2018B&amp;R group\u2019), 149 with the titration regime (\u2018titration group\u2019) and 78 with both regimes. The number of thyroid function tests (<jats:styled-content style=\"fixed-case\">TFT<\/jats:styled-content>s) performed per year (mean(<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>): 3\u00b72(1\u00b72) <jats:italic>vs<\/jats:italic> 3\u00b74(1\u00b75); adjusted mean difference\u00a0=\u00a0\u22120\u00b74; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: \u22120\u00b77 to \u22120\u00b71; and <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7008) and the number of hospital clinic visits per year (mean (<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>): 2\u00b79 (1\u00b70) <jats:italic>vs<\/jats:italic> 3\u00b72 (1\u00b73); adjusted mean difference\u00a0=\u00a0\u22120\u00b74; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: \u22120\u00b77 to \u22120\u00b72; and <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7002) were lower in the B&amp;R group than the titration group. The number of abnormal <jats:styled-content style=\"fixed-case\">TFT<\/jats:styled-content> results per year was similar in the two groups (mean(<jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>): 1\u00b78(1\u00b73) <jats:italic>vs<\/jats:italic> 1\u00b78(1\u00b74); adjusted mean difference\u00a0=\u00a00\u00b705; 95%<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>: \u22120\u00b73 to 0\u00b74; and <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b774).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this retrospective study, there was little evidence that patients under B&amp;R have more stable thyroid function. Further data from prospective studies, however, are needed to confirm this finding.<\/jats:p><\/jats:sec>","DOI":"10.1111\/cen.12478","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T11:03:00Z","timestamp":1399374180000},"page":"610-613","source":"Crossref","is-referenced-by-count":28,"title":["Block &amp; replace regime versus titration regime of antithyroid drugs for the treatment of Graves\u2019 disease: a retrospective observational study"],"prefix":"10.1111","volume":"81","author":[{"given":"Bijay","family":"Vaidya","sequence":"first","affiliation":[{"name":"Department of Endocrinology Royal Devon &amp; Exeter Hospital Exeter UK"},{"name":"NIHR CLAHRC South West Peninsula (PenCLAHRC) University of Exeter Medical School Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailsa","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Royal Devon &amp; Exeter Hospital Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Shuttleworth","sequence":"additional","affiliation":[{"name":"NIHR CLAHRC South West Peninsula (PenCLAHRC) University of Exeter Medical School Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie","family":"Donohoe","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Royal Devon &amp; Exeter Hospital Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Warren","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Royal Devon &amp; Exeter Hospital Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Brooke","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Royal Devon &amp; Exeter Hospital Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Gericke","sequence":"additional","affiliation":[{"name":"The Wesley Research Institute Brisbane Australia"},{"name":"University of Queensland Schools of Medicine &amp; Population Health and Queensland Brain Institute Brisbane Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obioha C","family":"Ukoumunne","sequence":"additional","affiliation":[{"name":"NIHR CLAHRC South West Peninsula (PenCLAHRC) University of Exeter Medical School Exeter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,19]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra042972"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2802"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60782-4"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP.17.3.456"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03097.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02169"},{"issue":"1","key":"e_1_2_7_8_1","first-page":"CD003420","article-title":"Antithyroid drug regimen for treating Graves\u2019 hyperthyroidism","author":"Abraham P.","year":"2010","journal-title":"Cochrane Database Systematic Review"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010263431707"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14073-1"},{"key":"e_1_2_7_11_1","unstructured":"Joint Formulary Exeter and Eastern Devon.Hyperthyroidism.http:\/\/www.exejointformulary.nhs.uk\/chapters\/endocrine\/thyroid_disorders\/hyperthyroidism\/(accessed 6 February 2014)."},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2008.0364"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K05-068"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02135.x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2221"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcen.12478","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.12478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T06:12:44Z","timestamp":1695535964000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.12478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,19]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1111\/cen.12478"],"URL":"https:\/\/doi.org\/10.1111\/cen.12478","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,19]]}}}